Ares Capital Corporation (NASDAQ: ARCC) is a Financial Services company in the Asset Management industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 14.56 | EPS (ttm) | 1.35 | Insider Own | 0.94% | Shs Outstand | 718.02M | Perf Week | 3.20% |
| Market Cap | 14.11B | Forward P/E | 10.17 | EPS next Y | 1.93 | Insider Trans | 0.55% | Shs Float | 713.78M | Perf Month | 5.87% |
| Enterprise Value | 29.45B | PEG | - | EPS next Q | 0.48 | Inst Own | - | Short Float | 6.35% | Perf Quarter | 2.45% |
| Income | 960.00M | P/S | 6.64 | EPS this Y | 41.15% | Inst Trans | - | Short Ratio | 8.40 | Perf Half Y | 0.67% |
| Sales | 2.13B | P/B | 1.00 | EPS next Y | 1.42% | ROA | 3.15% | Short Interest | 45.29M | Perf YTD | -2.87% |
| Book/sh | 19.59 | P/C | 27.94 | EPS next 5Y | -1.29% | ROE | 6.78% | 52W High | 22.76 -13.66% | Perf Year | -12.24% |
| Cash/sh | 0.70 | P/FCF | 12.67 | EPS past 3/5Y | 16.05% 10.29% | ROIC | 167.75% | 52W Low | 17.40 12.93% | Perf 3Y | 0.51% |
| Dividend Est. | 1.92 (9.77%) | EV/EBITDA | 23.41 | Sales past 3/5Y | 23.30% 21.18% | Gross Margin | 64.14% | Volatility | 2.09% 1.67% | Perf 5Y | -2.34% |
| Dividend TTM | 1.92 (9.77%) | EV/Sales | 13.86 | EPS Y/Y TTM | -44.67% | Oper. Margin | 59.67% | ATR (14) | 0.34 | Perf 10Y | 28.60% |
| Dividend Ex-Date | Sep 15, 2026 | Quick Ratio | 0.00 | Sales Y/Y TTM | -10.22% | Profit Margin | 45.18% | RSI (14) | 66.05 | Recom | 2.25 |
| Dividend Gr. 3/5Y | 0.88% 3.71% | Current Ratio | 0.00 | EPS Q/Q | -6.00% | SMA20 | 4.10% | Beta | 0.63 | Target Price | 19.00 |
| Payout | 138.44% | Debt/Eq | 1.12 | Sales Q/Q | 0.35% | SMA50 | 4.99% | Rel Volume | 1.35 | Prev Close | 19.17 |
| Employees | 4,250 | LT Debt/Eq | 1.12 | Earnings | Oct 27 | SMA200 | 1.72% | Avg Volume | 5.06M | Price | 19.65 |
| IPO Date | Oct 05, 2004 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -0.65% -0.28% | Net Debt/EBITDA | -0.30 | Volume | 6,821,150 | Change | 2.50% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight | $21 → $19 |
| Oct-29-25 | Reiterated | RBC Capital | Outperform | $22 → $23 |
| Oct-29-25 | Reiterated | Wells Fargo | Overweight | $22 → $21 |
| Oct-14-25 | Reiterated | UBS | Neutral | $22 → $21 |
| Oct-10-25 | Initiated | Lucid Capital | Buy | $23 |
| Jul-31-25 | Reiterated | JMP Securities | Market Outperform | $22 → $23 |
| Jul-30-25 | Upgrade | B. Riley Securities | Neutral → Buy | $24 |
| Feb-06-25 | Downgrade | Raymond James | Outperform → Market Perform | |
| Dec-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight | |
| Jul-30-24 | Reiterated | JMP Securities | Market Outperform | $22 |
Ares Capital Corporation (ARCC) operates as a Business Development Company (BDC), delivering diverse financing solutions predominantly to middle-market enterprises. The firm's expertise lies in facilitating various corporate actions, including funding acquisitions, recapitalizations, and leveraged buyouts. It also extends mezzanine debt, assists with corporate restructurings, and provides crucial rescue financing, in addition to offering growth capital and general refinancing options. ARCC primarily targets investments in companies within the basic and growth manufacturing, business services, consumer products, healthcare (both products and services), and information technology service sectors. Opportunistically, it also explores prospects in industries such as restaurants, retail, oil and gas, and the broader technology space. Geographically, ARCC maintains a broad reach across the United States. Its New York office oversees investments in the Northeast, Mid-Atlantic, Southeast, and Southwest regions. The Chicago office manages opportunities in the Midwest, while its Los Angeles presence covers the Western region. In terms of deal parameters, ARCC typically commits between $20 million and $200 million per investment, with an upper limit of $400 million, targeting companies that generate an EBITDA of $10 million to $250 million. For debt-specific placements, the investment range is generally $10 million to $100 million. The company employs a wide array of financial instruments, including revolving credit facilities, first and second lien loans, unitranche structures, warrants, mezzanine debt, private high yield, junior capital, and subordinated debt, alongside selective non-control preferred and common equity investments. ARCC also evaluates participation in senior and subordinated debt financings led by other parties and strategically acquires stressed or discounted debt. It frequently assumes a lead or agent role in its transactions and actively seeks board representation in its portfolio companies.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,125 | 2,242 | 2,367 | 2,166 | 1,196 | 2,050 | 858 | 1,115 | 1,119 | |
| Cost of Goods Sold Incl. D&A | 762 | 736 | 659 | 530 | 455 | 372 | 317 | 291 | 240 | |
| Gross Profit | 1,363 | 1,506 | 1,708 | 1,636 | 741 | 1,678 | 541 | 824 | 879 | |
| Selling, General and Administrative Excl. Other | 52 | 51 | 43 | 42 | 38 | 39 | 38 | 45 | 42 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 43 | 57 | 70 | 52 | 48 | 43 | 0 | -30 | -40 | |
| Operating Income | 1,268 | 1,398 | 1,595 | 1,542 | 655 | 1,596 | 503 | 809 | 877 | |
| Interest Expense | 803 | 736 | 659 | 530 | 455 | 372 | 317 | 291 | 240 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 599 | 736 | 659 | 530 | 455 | 372 | 317 | 291 | 240 | |
| Net Income Before Taxes | 1,064 | 1,398 | 1,595 | 1,542 | 655 | 1,596 | 503 | 809 | 877 | |
| Income Taxes | 104 | 99 | 73 | 20 | 55 | 29 | 19 | 16 | 19 | |
| Consolidated Net Income | 960 | 1,299 | 1,522 | 1,522 | 600 | 1,567 | 484 | 793 | 858 | |
| Net Income From Continuing Operations | 960 | 1,299 | 1,522 | 1,522 | 600 | 1,567 | 484 | 793 | 858 | |
| Net Income | 960 | 1,299 | 1,522 | 1,522 | 600 | 1,567 | 484 | 793 | 858 | |
| EPS (Recurring) | 1.35 | 1.86 | 2.44 | 2.75 | 1.21 | 3.51 | 1.14 | 1.86 | 2.01 | |
| EPS (Basic, Before Extraordinaries) | 1.35 | 1.86 | 2.44 | 2.75 | 1.21 | 3.51 | 1.14 | 1.86 | 2.01 | |
| EPS (Diluted) | 1.35 | 1.86 | 2.44 | 2.68 | 1.19 | 3.51 | 1.14 | 1.86 | 2.01 | |
| EBITDA | 1,258 | 1,398 | 1,595 | 1,542 | 655 | 1,596 | 503 | 809 | 877 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 14.56 | 10.88 | 8.97 | 7.47 | 15.52 | 6.04 | 14.82 | 10.03 | 7.75 | |
| Price To Sales Ratio | 6.64 | 6.31 | 5.77 | 5.12 | 7.69 | 4.61 | 8.35 | 7.14 | 5.93 | |
| Gross Margin | 64.14 | 67.17 | 72.16 | 75.53 | 61.96 | 81.85 | 63.05 | 73.90 | 78.55 | |
| Operating Margin | 59.67 | 62.36 | 67.38 | 71.19 | 54.77 | 77.85 | 58.62 | 72.56 | 78.37 | |
| Net Margin | 45.18 | 57.94 | 64.30 | 70.27 | 50.17 | 76.44 | 56.41 | 71.12 | 76.68 | |
| Shares Outstanding | 718 | 699 | 624 | 554 | 498 | 446 | 424 | 427 | 426 | |
| Market Capitalization | 14,109 | 14,141 | 13,659 | 11,097 | 9,198 | 9,451 | 7,161 | 7,964 | 6,637 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MARKOWICZ JANA | Chief Operating Officer | Feb 09 '26 | Buy | 19.20 | 15,000 | 288,000 | 25,176 | Feb 10 |
| Lem Scott C | CFO and Treasurer | Feb 06 '26 | Buy | 19.29 | 5,186 | 100,038 | 39,463 | Feb 09 |
| HENSON MARY BETH | Director | Feb 05 '26 | Buy | 19.14 | 4,000 | 76,560 | 31,913 | Feb 09 |
| SCHNABEL MICHAEL KORT | Chief Executive Officer | Feb 05 '26 | Buy | 19.13 | 12,500 | 239,125 | 40,500 | Feb 09 |
| SCHNABEL MICHAEL KORT | Chief Executive Officer | Oct 31 '25 | Buy | 20.39 | 13,000 | 265,070 | 28,000 | Nov 03 |
| Miller James Robert | Co-President | Mar 03 '25 | Buy | 23.32 | 40,000 | 932,800 | 40,000 | Mar 05 |
| Bates Ann Torre | Director | Feb 11 '25 | Buy | 22.75 | 6,000 | 136,500 | 30,000 | Feb 13 |
| SCHNABEL MICHAEL KORT | Co-President | May 02 '23 | Buy | 17.84 | 15,000 | 267,600 | 15,000 | May 04 |
| ROLL PENELOPE F | Chief Financial Officer | Mar 16 '23 | Buy | 17.44 | 3,000 | 52,320 | 60,500 | Mar 17 |
| ROLL PENELOPE F | Chief Financial Officer | Mar 15 '23 | Buy | 17.50 | 3,000 | 52,500 | 57,500 | Mar 17 |
| ROLL PENELOPE F | Chief Financial Officer | Sep 14 '22 | Buy | 19.04 | 2,500 | 47,600 | 54,500 | Sep 16 |
| HENSON MARY BETH | director: | Aug 31 '22 | Buy | 19.77 | 9,000 | 177,930 | 20,000 | Sep 02 |
| ROLL PENELOPE F | Chief Financial Officer | Aug 03 '22 | Buy | 19.77 | 25,000 | 494,250 | 52,000 | Aug 04 |
| McKeever Steven B. | director: | Jun 15 '22 | Buy | 17.95 | 2,775 | 49,811 | 44,944 | Jun 17 |
| Arougheti Michael J | Executive Vice President | Jun 14 '22 | Buy | 17.75 | 300,000 | 5,325,000 | 1,782,709 | Jun 16 |